SCHEMBL12475448

SCHEMBL12475448

CCSCNCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5566705 0.77 TSHR (0.54)
SCHEMBL948275 0.73
SCHEMBL41068 0.71
Butane SCHEMBL2590833 0.71 FFAR3 (0.53)
SCHEMBL13041717 0.70 ALDH1A1 (0.39)
SCHEMBL4816014 0.69 LMNA (0.50)
SCHEMBL27023 0.69
Hydrochloric Acid SCHEMBL23174893 0.69
SCHEMBL31198194 0.69
Hydrochloric Acid SCHEMBL272523 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3008037-B1 HYDROXY-ETHYLENE DERIVATIVES FOR THE TREATMENT OF ARTHROSIS MERCK PATENT GMBH (DE) 2018-09-26 EP claimed
EP-2673287-B1 AMINO STATIN DERIVATIVES FOR THE TREATMENT OF ARTHROSIS MERCK PATENT GMBH (DE) 2017-08-30 EP claimed
EP-3008037-A1 HYDROXY-ETHYLENE DERIVATIVES FOR THE TREATMENT OF ARTHROSIS Merck Patent GmbH (DE) 2016-04-20 EP claimed
CN-105263900-A Hydroxy-ethylene derivatives for the treatment of arthrosis MERCK PATENT GMBH 2016-01-20 CN claimed
EP-2877485-A1 HYDROXYSTATIN DERIVATIVES FOR TREATMENT OF ARTHROSIS Merck Patent GmbH (DE) 2015-06-03 EP claimed
WO-2014198372-A1 HYDROXY-ETHYLENE DERIVATIVES FOR THE TREATMENT OF ARTHROSIS MERCK PATENT GMBH (DE) 2014-12-18 WO claimed
WO-2014015934-A1 HYDROXYSTATIN DERIVATIVES FOR TREATMENT OF ARTHROSIS MERCK PATENT GMBH (DE) 2014-01-30 WO claimed
EP-2673287-A1 AMINO STATIN DERIVATIVES FOR THE TREATMENT OF ARTHROSIS Merck Patent GmbH (DE) 2013-12-18 EP claimed
WO-2012107153-A1 AMINO STATIN DERIVATIVESFOR THE TREATMENT OF ARTHROSIS MERCK PATENT GMBH (DE) 2012-08-16 WO claimed
CN-105263900-B Hydroxy ethylene derivatives for the treatment of arthrosis 默克专利股份公司 2020-09-22 CN disclosed
EP-3008037-B1 HYDROXY-ETHYLENE DERIVATIVES FOR THE TREATMENT OF ARTHROSIS MERCK PATENT GMBH (DE) 2018-09-26 EP disclosed
EP-2877485-B1 HYDROXYSTATIN DERIVATIVES FOR TREATMENT OF ARTHROSIS MERCK PATENT GMBH (DE) 2018-03-14 EP disclosed
EP-2673287-B1 AMINO STATIN DERIVATIVES FOR THE TREATMENT OF ARTHROSIS MERCK PATENT GMBH (DE) 2017-08-30 EP disclosed
EP-3008037-A1 HYDROXY-ETHYLENE DERIVATIVES FOR THE TREATMENT OF ARTHROSIS Merck Patent GmbH (DE) 2016-04-20 EP disclosed
EP-2877485-A1 HYDROXYSTATIN DERIVATIVES FOR TREATMENT OF ARTHROSIS Merck Patent GmbH (DE) 2015-06-03 EP disclosed
WO-2014198372-A1 HYDROXY-ETHYLENE DERIVATIVES FOR THE TREATMENT OF ARTHROSIS MERCK PATENT GMBH (DE) 2014-12-18 WO disclosed
WO-2014111113-A1 ACYLGUANIDINES FOR TREATING OSTEOARTHRITIS MERCK PATENT GMBH (DE) 2014-07-24 WO disclosed
WO-2014015934-A1 HYDROXYSTATIN DERIVATIVES FOR TREATMENT OF ARTHROSIS MERCK PATENT GMBH (DE) 2014-01-30 WO disclosed
EP-2673287-A1 AMINO STATIN DERIVATIVES FOR THE TREATMENT OF ARTHROSIS Merck Patent GmbH (DE) 2013-12-18 EP disclosed
WO-2012107153-A1 AMINO STATIN DERIVATIVESFOR THE TREATMENT OF ARTHROSIS MERCK PATENT GMBH (DE) 2012-08-16 WO disclosed